Immunophenotypic analysis reveals differences in circulating immune cells in the peripheral blood of patients with segmental and nonsegmental vitiligo

Autor: Willemsen, M., Post, N.F., van Uden, N.O.P., Narayan, V.S., Chielie, S., Kemp, E.H., Bekkenk, M.W., Luiten, R.M.

Accumulating studies have indicated immune-based destruction of melanocytes in both segmental vitiligo (SV) and non-SV (NSV). Whereas SV often occurs unilaterally during childhood and stabilizes after an initial period of activity, the disease course

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::1db7d2b68ad1c0e861ef74bbf57f64b2
https://eprints.whiterose.ac.uk/176921/7/1-s2.0-S0022202X2101349X-main.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Immunophenotypic Analysis Reveals Differences in Circulating Immune Cells in the Peripheral Blood of Patients with Segmental and Nonsegmental Vitiligo.

Autor: Willemsen M; Netherlands Institute for Pigment Disorders, Department of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands. Electronic address: m.willemsen@amsterdamumc.nl., Post NF; Netherlands Institute for Pigment Disorders, Department of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands., van Uden NOP; Netherlands Institute for Pigment Disorders, Department of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands., Narayan VS; Netherlands Institute for Pigment Disorders, Department of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands., Chielie S; Netherlands Institute for Pigment Disorders, Department of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands., Kemp EH; Department of Oncology and Metabolism, The Medical School, The University of Sheffield, Sheffield, United Kingdom., Bekkenk MW; Netherlands Institute for Pigment Disorders, Department of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands., Luiten RM; Netherlands Institute for Pigment Disorders, Department of Dermatology, Amsterdam University Medical Center, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands.

Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2022 Mar; Vol. 142 (3 Pt B), pp. 876-883.e3. Date of Electronic Publication: 2021 Jun 22.